Vitamin-D-Mangel als Risikofaktor für Autoimmunerkrankungen, Diabetes mellitus und Herz-Kreislauf-Erkrankungen

Zusammenfassung

Vitamin D kann oral aufgenommen oder endogen in der Haut unter dem Einfluss von UV-Strahlung gebildet werden. In der Leber folgt eine Hydroxylierung zum 25-Hydroxy-Vitamin D₃ und in der Niere eine weitere Hydroxylierung zu 1,25-Dihydroxy-Vitamin D₃ (Calcitriol), einem wichtigen Steroidhormon. Calcitriol ist der aktivste Vitamin-D-Metabolit im Calciumstoffwechsel. Auch verschiedene andere Gewebe können Calcitriol bilden und einen Vitamin-D-Rezeptor exprimieren; dies weist auf eine physiologische Rolle von Vitamin D hin, die über den Calciumstoffwechsel und die Knochenbildung hinausgeht. Epidemiologische Daten zeigen einen niedrigen Vitamin-D-Status bzw. -Mangel bei Patienten mit Autoimmunerkrankungen wie Multipler Sklerose, rheumatoider Arthritis und entzündlichen Darmerkrankungen sowie bei Diabetikern und bei Patienten mit Herzinsuffizienz und Hypertonie. Die Gabe von Vitamin D kann günstige Wirkungen bei diesen Erkrankungen haben.

Die aktuellen Zufuhrempfehlungen der Deutschen Gesellschaft für Ernährung bezüglich Vitamin D betragen 5 μg für den erwachsenen Menschen (10 μg für Patienten über 65 Jahre). Diese Zufuhr ist in der Regel nicht ausreichend, um optimale Serumkonzentrationen von Vitamin D einzustellen. Eine ungenügende Vitamin-D-Versorgung kann mit verschiedenen chronischen Erkrankungen des älteren Menschen korrelieren wie Autoimmunerkrankungen, Diabetes, Hypertonie, Herzinsuffizienz und verschiedenen Tumoren.

Summary

Vitamin D formed in the skin after exposure to UV-light or orally ingested is metabolized in the liver to 25-hydroxy-vitamin D₃ and further more in the kidney to 1,25-dihydroxy-vitamin D₃, calcitriol, an important steroid hormone. Also different other tissues are capable of producing calcitriol or possess a vitamin-D-receptor and this indicates a physiological role of vitamin D exceeding the regulation of calcium metabolism and bone formation. Epidemiological data indicate an insufficient vitamin D status in patients with autoimmune disorders such as multiple sclerosis, rheumatoid arthritis and inflammatory bowel disease, in diabetic patients and in patients with congestive heart failure and hypertension. Vitamin D supplementation may have beneficial effects in these disorders and can e.g. suppress the induction of autoimmune encephalomyelitis, an animal model of MS and has been shown to improve clinical symptoms in patients with rheumatoid arthritis. In type 1 diabetes it can influence the autoimmune process and in type 2 diabetes it can improve insulin resistance. Reduction of blood pressure was also shown under vitamin D supplementation in normotensive as well as hypertensive patients and patients with congestive heart failure often exhibit vitamin D deficiency.

The recommended dietary allowance for vitamin D for adults in Germany is 5 μg (10 μg for elderly people) but this dose may be insufficient to achieve optimal serum concentrations of vitamin D and vitamin D deficiency may be associated with different chronic disorders of elderly people such as autoimmune disorders, diabetes, hypertension, congestive heart failures, and some types of cancer.

Vitamin D - Steroidhormon - Autoimmunerkrankungen - Diabetes - Hypertonie - Herzinsuffizienz - Zufuhrempfehlungen

Vitamin D - steroid hormone - autoimmune disorders - diabetes - hypertension - congestive heart failure - recommended dietary allowances

Literatur

• 1 Aguado P. et al. . Low vitamin D levels in outpatient post-menopausal women from a rheumatology clinic in Madrid, Spain: their relationship with bone mineral density.  Osteoporos Int. 2000;  11 739-744
• 2 Aksoy H. et al. . Serum 1,25-dihydroxy-vitamin D (1,25(OH)₂D₃), 25-hydroxy-vitamin D (25(OH)D₃) and parathormone levels in diabetic retinopathy.  Clin Biochem. 2000;  33 47-51
• 3 Andjelkovic Z. et al. . Disease modifying and immunomodulatory effects of high dose 1-alpha-(OH)-D₃ in rheumatoid arthritis patients.  Clin Exp Rheumatol. 1999;  17 453-456
• 4 Barger-Lux MJ. et al. . An investigation of sources of variation in calcium absorption efficiency.  J Clin Endocrinol Metab. 1995;  80 406-411
• 5 Bayer W. Endemischer Vitamin-D-Mangel in Mitteleuropa?.  [Editorial] Ernährung & Medizin. 2004;  19 55
• 6 Bayer W, Schmidt K. Besteht in Mitteleuropa ein endemischer Vitamin-D-Mangel?.  Erfahrungsheilkunde. 2004;  53 609-613
• 7 Baynes KC. et al. . Vitamin D, glucose tolerance and insulinaemia in elderly men.  Diabetologia. 1997;  40 344-347
• 8 Borissova AM. et al. . The effect of vitamin D₃ on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients.  Int J Clin Pract. 2003;  57 258-261
• 9 Bucher HC. et al. . Effect of calcium supplementation on blood pressure: a meta-analysis of randomized controlled trials.  JAMA. 1996;  275 1016-1022
• 10 Burgess ED. et al. . Interaction of 1,25-dihydroxyvitamin D and plasma renin activity in high renin essential hypertension.  Am J Hypertens. 1990;  3 903-905
• 11 Cantorna MT. Vitamin D and autoimmunity: Is vitamin D status an environmental factor affecting autoimmune disease prevalence?.  Proc Soc Exp Biol Med. 2000;  223 230-233
• 12 Cantorna MT, Hayes CE, DeLuca HF. 1,25-dihydroxyvitamin D₃ reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis.  Proc Natl Acad Sci USA. 1996;  93 7861-7864
• 13 Cantorna MT, Humpal-Winter J, DeLuca HF. In vivo upregulation of interleukin-4 is one mechanism underlying the immunoregulatory effects of 1,25-dihydroxyvitamin D₃.  Arch Biochem Biophys. 2000;  377 135-138
• 14 Cantorna MT, Munsick C. et al. . 1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease.  J Nutr. 2000;  130 2648-2652
• 15 Cosman F. et al. . Fracture history and bone loss in patients with MS.  Neurology. 1998;  51 1161-1165
• 16 DeLuca HF, Cantorna MT. Vitamin D: Its role and uses in immunology.  FASEB J. 2001;  15 2579-2585
• 17 Fukazawa T. et al. . Association of vitamin D receptor gene polymorphism with multiple sclerosis in Japanese.  J Neurol Sci. 1999;  166 47-52
• 18 Goertz B. et al. . Vitamin D receptor genotypes are not associated with rheumatoid arthritis or biochemical parameters of bone turnover in German RA patients.  Clin Exp Rheumatol. 2003;  21 333-339
• 19 Harries AD. et al. . Vitamin D status in Crohn's disease: association with nutrition and disease activity.  Gut. 1985;  26 1197-1203
• 20 Hayes CE. et al. . The immunological functions of the vitamin D endocrine system.  Cell Mol Biol (Noisy-le-grand). 2003;  49 277-300
• 21 Hein G, Oelzner P. Vitamin D metabolites in rheumatoid arthritis: findings - hypotheses - consequences.  Z Rheumatol. 2000;  59 28-32
• 22 Hyppönen E. et al. . Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study.  Lancet. 2001;  358 1500-1503
• 23 Isaia G. et al. . High prevalence of hypovitaminosis D in female type 2 diabetic population.  Diabetes Care. 2001;  24 1496
• 24 Jahnsen J. et al. . Vitamin D status, parathyroid hormone and bone mineral density in patients with inflammatory bowel disease.  Scand J Gastroenterol. 2002;  37 192-199
• 25 Jespersen B. et al. . Acute cardiovascular effect of 1,25-dihydroxycholecalciferol in essential hypertension.  Am J Hypertens. 1998;  11 659-666
• 26 Kimura. et al. . Effectiveness of 1,25-dihydroxyvitamin D₃ supplementation on blood pressure reduction in a pseudohypoparathyroidism patient with high renin activity.  Intern Med. 1999;  38 31-35
• 27 Krause R. et al. . Ultraviolet B and blood pressure.  Lancet. 1998;  352 709-710
• 28 Kristal-Boneh E, Froom P. et al. . Association of calcitriol and blood pressure in normotensive men.  Hypertension. 1997;  30 1289-94
• 29 Krüger C. et al. . Intracellular calcium handling in isolated ventricular myocytes from cardiomyopathic hamsters (strain BIO 14.6) with congestive heart failure.  Cell Calcium. 1994;  16 500-508
• 30 Lange U. et al. . Relationship between disease activity and serum levels of vitamin D metabolites and parathyroid hormone in ankylosing spondylitis.  Osteoporos Int. 2001;  12 1031-1035
• 31 Lemire JM, Adams JS. 1,25-dihydroxyvitamin D₃ inhibits the passive transfer of cellular immunity by a myelin basic protein-specific T-cell clone.  J Bone Miner Res. 1992;  7 171-177
• 32 Li YC, Kong J, Wei M. et al. . 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system.  J Clin Invest. 2002;  110 229-238
• 33 Li YC, Qiao G. et al. . Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure.  J Steroid Biochem Mol Biol. 2004;  89-90 387-392
• 34 Lind L, Hanni A, Lithell H. et al. . Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men.  Am J Hypertens. 1995;  8 894-901
• 35 Lind L, Lithell H. et al. . Reduction of blood pressure by treatment with alphacalcidol. A double-blind, placebo-controlled study in subjects with impaired glucose tolerance.  Acta Med Scand. 1988;  223 211-217
• 36 Lind L, Wengle B, Wide L. et al. . Hypertension in primary hyperparathyroidism - reduction of blood pressure by long-term treatment with vitamin D (alphacalcidol). A double-blind, placebo-controlled study.  Am J Hypertens. 1988;  1 397-402
• 37 Lind L, Wengle B, Wide L. et al. . Reduction of blood pressure during long-term treatment with active vitamin D (alphacalcidol) is dependent on plasma renin activity and calcium status. A double-blind, placebo-controlled study.  Am J Hypertens. 1989;  2 20-25
• 38 Mahon BD, Gordon SA. et al. . The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells.  J Cell Biochem. 2003;  89 922-932
• 39 Mahon BD, Wittke A. et al. . Cytokine profile in patients with multiple sclerosis following vitamin D supplementation.  J Neuroimmunol. 2003;  134 128-132
• 40 Meehan MA. et al. . 1,25-Dihydroxyvitamin D₃ enhances generation of non-specific suppressor cells while inhibiting the induction of cytotoxic cells in a human MLR.  Cell Immunol. 1992;  140 400-409
• 41 Meehan TF, DeLuca HF. CD8⁺ T cells are not necessary for 1,25-dihydroxyvitamin D₃ to suppress experimental autoimmune encephalomyelitis in mice.  Proc Natl Acad Sci USA. 2002;  99 5557-5560
• 42 Merlino LA. et al. . Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study.  Arthritis Rheum. 2004;  50 72-77
• 43 Motohashi Y. et al. . Vitamin D receptor gene polymorphism affects onset pattern of type 1 diabetes.  J Clin Endocrinol Metab. 2003;  88 3137-3140
• 44 Munger KL. et al. . Vitamin D intake and incidence of multiple sclerosis.  Neurology. 2004;  62 60-65
• 45 Nakamura H. et al. . High serum and synovial fluid granulocyte colony stimulating factor (G-CSF) concentrations in patients with rheumatoid arthritis.  Clin Exp Rheumatol. 2000;  18 713-718
• 46 Nieves J. et al. . High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis.  Neurology. 1994;  44 1687-92
• 47 Nishio K. et al. . Congestive heart failure is associated with the rate of bone loss.  J Intern Med. 2003;  253 439-446
• 48 Oelzner P.. et al. . Relationship between disease activity and serum levels of vitamin D metabolites and PTH in rheumatoid arthritis.  Calcif Tissue Int. 1998;  62 193-198
• 49 Oh JY, Barrett-Connor E. Association between vitamin D receptor polymorphism and type 2 diabetes or metabolic syndrome in community-dwelling older adults: the Rancho Bernardo Study.  Metabolism. 2002;  51 356-359
• 50 Ortlepp JR. et al. . The vitamin D receptor gene variant is associated with the prevalence of type 2 diabetes mellitus and coronary artery disease.  Diabet Med. 2001;  18 842-845
• 51 Pfeifer M. et al. . Effects of a short-term vitamin D₃ and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women.  J Clin Endocrinol Metab. 2001;  86 1633-1637
• 52 Rostand SG. Ultraviolet light may contribute to geopraphic and racial blood pressure differences.  Hypertension. 1997;  30 150-156
• 53 Shane E. et al. . Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure.  Am J Med. 1997;  103 197-207
• 54 Siffledeen JS. et al. . The frequency of vitamin D deficiency in adults with Crohn's disease.  Can J Gastroenterol. 2003;  17 473-478
• 55 Sigmund CD. Regulation of renin expression and blood pressure by vitamin D₃.  J Clin Invest. 2002;  110 155-156
• 56 Silvennoinen J. Relationships between vitamin D, parathyroid hormone and bone mineral density in inflammatory bowel disease.  J Intern Med. 1996;  239 131-137
• 57 Simmons JD. et al. . Vitamin D receptor gene polymorphism: association with Crohn's disease susceptibility.  Gut. 2000;  47 211-214
• 58 Simpson RU, Weishaar RE. Involvement of 1,25-dihydroxyvitamin D₃ in regulating myocardial calcium metabolism: physiological and pathological actions.  Cell Calcium. 1988;  9 285-292
• 59 Skrabic V. et al. . Vitamin D receptor polymorphism and susceptibility to type 1 diabetes in the Dalmatian population.  Diabetes Res Clin Pract. 2003;  59 31-35
• 60 Stio M. et al. . Suppressive effect of 1,25-dihydroxyvitamin D₃ and its analogues EB 1089 and KH 1060 on T lymphocyte proliferation in active ulcerative colitis.  Biochem Pharmacol. 2001;  61 365-371
• 61 Takeuchi A. et al. . Nuclear factor of activated T cells (NFAT) as a molecular target for 1,25-dihydroxyvitamin D₃-mediated effects.  J Immunol. 1998;  160 209-218
• 62 Tsuda K. et al. . Bone mineral density in women with essential hypertension.  Am J Hypertens. 2001;  14 704-707
• 63 van Amerongen BM, Dijkstra CD. et al. . Multiple sclerosis and vitamin D: an update.  Eur J Clin Nutr. 2004;  58 1095-1109
• 64 van Etten E, Decallonne B, Mathieu C. 1,25-dihydroxycholecalciferol: endocrinology meets the immune system.  Proc Nutr Soc. 2002;  61 375-380
• 65 von Tirpitz C, Steder-Neukamm U. et al. . Osteoporosis in inflammatory bowel disease - results of a survey among members of the German Crohn's and Ulcerative Colitis Association.  Z Gastroenterol. 2003;  41 1145-50
• 66 Watson KE. et al. . Active serum vitamin D levels are inversely correlated with coronary calcification.  Circulation. 1997;  96 1755-60
• 67 Wortsman J. et al. . Decreased bioavailability of vitamin D in obesity.  Am J Clin Nutr. 2000;  72 690-693
• 68 Young EW. et al. . Regulation of parathyroid hormone and vitamin D in essential hypertension.  Am J Hypertens. 1995;  8 957-964
• 69 Zella JB. et al. . Oral administration of 1,25-dihydroxyvitamin D₃ completely protects NOD mice from insulin-dependent diabetes mellitus.  Arch Biochem Biophys. 2003;  417 77-80
• 70 Zittermann A. et al. . Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure?.  J Am Coll Cardiol. 2003;  41 105-112